Resmed Inc. buy JPMorgan Chase & Co.
Start price
31.01.25
/
50%
€233.00
Target price
31.01.26
€274.39
Performance (%)
-4.93%
Price
12.01.26
€221.00
Summary
This prediction is currently active. With a performance of -4.93%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. A total of €0.51 was paid as dividends for this prediction. This prediction currently runs until 31.01.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 5.590% | 5.590% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $286.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat